Intra-arterial methylprednisolone for pediatric gastrointestinal post-transplant lymphoproliferative disorder

Pediatr Hematol Oncol. 2024 Apr;41(3):240-245. doi: 10.1080/08880018.2023.2267612. Epub 2023 Oct 20.

Authors

Hoyoung Jung¹, Ravjot Dhatt², S Rod Rassekh³, Manraj K S Heran²

Affiliations

¹ Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Radiology, British Columbia's Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
³ Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

PMID: 37861406
DOI: 10.1080/08880018.2023.2267612

No abstract available

MeSH terms

Child
Epstein-Barr Virus Infections*
Humans
Immunosuppressive Agents
Lymphoproliferative Disorders* / drug therapy
Lymphoproliferative Disorders* / etiology
Methylprednisolone / therapeutic use

Substances

Methylprednisolone
Immunosuppressive Agents